Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.
Lung Cancer Awareness: Dr. Melissa Johnson on Early Detection & Breakthrough Treatment|NewsChannel 5
Mike: A Story of Hope & The Power of Clinical Trials
How Blood Cancer Research Is Advancing Treatment | Dr. Hans Lee & Dr. Kris Patel on News Channel 5
What You Need to Know About Prostate Cancer Awareness | Dr. Benjamin Garmezy on News Channel 5
How Immunotherapy Is Transforming Cancer Care | Dr. David Spigel on News Channel 5
What You Need to Know About Sarcoma | Dr. Vivek Subbiah on News Channel 5
Clinical Trials 101
How We Offer Research Through SCRI
How Your Local Practice Fits into SCRI
How Clinical Trials Are Revolutionizing Cancer Treatment
SCRI New Hope
Dr. Erika Hamilton on Scripps News
SCRI's 26th Annual Scientific Meeting
Dr. Meredith McKean on mRNA Combined Immunotherapy for Melanoma – NBCLX
Blood Cancer Patient Receives Life-Saving Gift From Complete Stranger
Dr. Ben Garmezy on Prostate Cancer Awareness for LX News Now NBCLX
Dr. Navneet Majhail on NBCLX National for Blood Cancer Awareness Month
Tour Sarah Cannon Research Institute’s City View Drug Development Unit – Patients
Dr. Erika Hamilton on Late Stage Breast Cancer on LX News - NBCLX
Wife of Cancer Patient Inspired by Exceptional Care Becomes Oncology Nurse
2021 Sarah Cannon Media Highlights
Dr. Frangoul Discusses CRISPR's Impact on Treating Sickle Cell Disease - BCN
Dr. David Spigel Shares 2021 Cancer Research Updates - NBCLX
Dr. Erika Hamilton Shares an Important Breast Cancer Research Update - Newsy
Lake Mary Drug Development Unit Tour
Dr. Hamilton Discusses Trastuzumab deruxtecan - NBCLX
Lake Nona Drug Development Unit Tour
Dr. Erika Hamilton Discusses the Newly-Released Data on Cancer-Related Deaths - NBCLX